Kristie Ann Horner, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 790 College Pkwy, Colchester, VT 05446 Phone: 802-847-0407 |
Mrs. Nicola Pauline Hawko Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 790 College Pkwy, Colchester, VT 05446 Phone: 802-847-5778 |
Shannon Sixt, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 905 Roosevelt Hwy Ste 115, Colchester, VT 05446 Phone: 802-861-3600 |
Emily Staples Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 792 College Pkwy, Colchester, VT 05446 Phone: 802-847-0000 |
Stephanie Pierce, MSOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 790 College Pkwy, Colchester, VT 05446 Phone: 802-847-8791 |
News Archive
Patients overall in the United States are very satisfied with their physicians and with treatment they receive in outpatient settings, according to new information which challenges common public perceptions about outpatient medical treatment.
Dogs may not only be man's best friend, they may also have a special role in the lives of children with special needs. According to a new Universit- de Montreal study, specifically trained service dogs can help reduce the anxiety and enhance the socialization skills of children with Autism Syndrome Disorders (ASDs).
A new Boston University School of Public Health (BUSPH) study finds that the proportion of high school students identifying as lesbian, gay, bisexual, or questioning (LGBQ) doubled from 2009 to 2017, while the LGBQ teen rate of attempted suicide went from five times the rate for their straight peers to nearly four times the rate.
WaferGen Biosystems, Inc., a leading developer of state-of-the-art genetic analysis systems, today announced that the National Institutes of Health (NIH) awarded a grant to the University of Pittsburgh that includes funding of $350,000 over the grant period for WaferGen's SmartChip™ Real-Time PCR System. The researchers will conduct novel gene expression research in the areas of advanced lung disease and asthma and will use the SmartChip system as the key platform for high throughput validation.
This test, which we have branded SelectMDx for Prostate Cancer, came with the acquisition of a company in the Netherlands called NovioGendix. They developed a prototype assay, so they did most of the heavy lifting in terms of discovering the two specific biomarkers that are currently in the product. These biomarkers are tuned towards the detection of what I call clinically significant prostate cancer.
› Verified 6 days ago